Browse > Article
http://dx.doi.org/10.5352/JLS.2016.26.9.1063

Effects of Fermented Dandelion (Taraxacum coreanum) Extract on Male Climacteric Syndrome  

Lee, Hak Su (Department of Biomedical Science, Jungwon University)
Baek, Yeon Su (Department of Biomedical Science, Jungwon University)
Kim, Ye Seul (Department of Biomedical Science, Jungwon University)
Kim, Hyun Pyo (Department of Biomedical Science, Jungwon University)
Publication Information
Journal of Life Science / v.26, no.9, 2016 , pp. 1063-1073 More about this Journal
Abstract
Male climacteric syndrome, andropause, or testosterone deficiency syndrome (TDS) is one of the new health issues in elderly men. It is a natural phenomenon that happens with age in men, which is clinically characterized by a decline in levels of serum testosterone resulting in a significantly decreasing of physical and mental activities. The aim of this study was to investigate the putative alleviative effects of dandelion extract on the symptoms of TDS by increasing serum testosterone levels and compare the efficacy between dandelion extract (DE) and fermented dandelion extract (FDE). After daily intake of DE and FDE for 4 weeks, serum testosterone levels, muscles of vastus lateralis, forced swimming time, total sperm counts, and motile sperm counts were significantly increased in older rats (22 weeks). Additionally, SHBG, epididymal fat pad, total serum cholesterol and triglyceride were significantly decreased in DE and FDE fed groups. However, PSA levels were not different among all groups. Furthermore, DE and FDE enhanced the expression of genes related to testosterone biosynthesis in TM3 Leydig cells. Overall, these positive effects on andropause were greater in FDE compared to DE. These results suggest the potential of FDE as a safe and efficacious natural material for recovering testosterone levels and reducing andropause symptoms.
Keywords
Dandelion; male climacteric syndrome; Taraxacum coreanum; testosterone; testosterone deficiency syndrome;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Yakubu, M. T., Akanji, M. A. and Oladiji, A. T. 2005. Aphrodisiac potentials of the aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male albino rats. Asian J. Androl. 7, 399-404   DOI
2 Yoon, T. J. 2008. Effect of water extracts from root of Taraxacum officinale in innate and adaptive immune responses in mice. Kor. J. Food and Nutr. 21, 275-282.
3 Akashi, T., Furuno, T., Takahashi, T. and Ayabe, S. I. 1994. Biosynthesis of triterpenoids in cultured cells, and regenerated and wild plant organs of Taraxacum officinale. Phytochemistry 36, 303-308.   DOI
4 Araujo, A. B., Esche, G. R., Kupelian, V., O'Donnell, A. B., Travison, T. G., Williams, R. E., Clark, R. V. and McKinlay, J. B. 2007. Prevalence of symptomatic androgen deficiency in men. J. Clin. Endocr. Metab. 92, 4241-4247.   DOI
5 Aversa, A. and Morgentaler, A. 2015. The practical management of testosterone deficiency in men. Nat. Rev. Urol. 12, 641-650.   DOI
6 Borst, S. E. and Yarrow, J. F. 2015. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men. Am. J. Physiol. Endocrinol. Metab. 308, E1035-1042.   DOI
7 Castillo, O. A., López-Fontana, G., Vidal-Mora, I. and López Laur, J. D. 2015. Testosterone replacement therapy and prostate cancer: the downfall of a paradigm? Medwave 15, e6155.
8 Bratt, O. and Lilja, H. 2015. Serum markers in prostate cancer detection. Curr. Opin. Urol. 25, 59-64.   DOI
9 Budzianowski, J. 1997. Coumarins, caffeoyltartaric acids and their artifactual methyl esters from Taraxacum officinale leaves. Planta Med. 63, 288-289.   DOI
10 Buvat, J., Maggi, M., Gooren, L., Guay, A. T., Kaufman, J., Morgentaler, A., Schulman, C., Tan, H. M., Torres, L. O., Yassin, A. and Zitzmann, M. 2010. Endocrine aspects of male sexual dysfunctions. J. Sex. Med. 7, 1627-1656.   DOI
11 Davaatseren, M., Hur, H. J., Yang, H. J., Hwang, J. T., Park, J. H., Kim, H. J., Kwon, D. Y. and Sung, M. J. 2013. Taraxacum officinale (dandelion) leaf extract alleviates high-fat diet-induced nonalcoholic fatty liver. Food Chem. Toxicol. 58, 30-36.   DOI
12 Crawford, E. D. 2005. Testosterone substitution and the prostate. Eur. Urol. Suppl. 4, 16-23.
13 Cunningham, G. R. 2013. Andropause or male menopause? Rationale for testosterone replacement therapy in older men with low testosterone levels. Endocr. Pract. 19, 847-852.   DOI
14 Da-Nian, Q., She, B. R., She, Y. C. and Wang, J. H. 2002. Effects of flavonoids from Semen cuscutae on the reproductive system in male rats. Asian J. Androl. 2, 99-102.
15 Dias, J. P., Melvin, D., Simonsick, E. M., Carlson, O., Shardell, M. D., Ferrucci, L., Chia, C. W., Basaria, S. and Egan, J. M. 2016. Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized-controlled trial. Andrology 4, 33-40.   DOI
16 Hofer, H. G. 2011. Men in a critical age: Kurt Mendel and the controversy over the male climacterium. Urologe A. 50, 839-845.   DOI
17 Fernández-Miró, M., Chillarón, J. J. and Pedro-Bote, T. J. 2016. Testosterone deficiency, metabolic syndrome and diabetes mellitus. Med. Clin. (Barc) 146, 67-73.   DOI
18 Gaffari, T., Mustafa, S., Muhterem, A., Abdurrauf, Y., Seyfettin, G., Murat, Y., Emrah, H. A. and Hakan, A. 2008. Effects of pomegranate juice consumption on sperm quality, spermatogenic cell density, antioxidant activity and testosterone level in male rats. Clin. Nutr. 27, 289-296   DOI
19 Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M. and Sonksen, P. 2012. Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr. Rev. 33, 314-377.   DOI
20 González-Castejón, M., García-Carrasco, B., Fernández-Dacosta, R., Dávalos, A. and Rodriguez-Casado, A. 2014. Reduction of adipogenesis and lipid accumulation by Taraxacum officinale (Dandelion) extracts in 3T3L1 adipocytes: an in vitro study. Phytother. Res. 28, 745-752.   DOI
21 Handelsman, D. J., Sikaris, K. and Ly, L. P. 2016. Estimating age-specific trends in circulating testosterone and sex hormone-binding globulin in males and females across the lifespan. Ann. Clin. Biochem. 53, 377-384.   DOI
22 Hassan, J. and Barkin, J. 2016. Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy. Can. J. Urol. 23, 20-30.
23 Im, D. Y. and Lee, K. I. 2011. Antioxidative and antibacterial activity and tyrosinase inhibitory activity of the extract and fractions from Taraxacum coreanum Nakai. Kor. J. Med. Crop Sci. 19, 238-245.   DOI
24 Kaufman, J. M. and Vermeulen, A. 2005. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev. 26, 833-876.   DOI
25 Jinchun, Z. and Jie, C. 2011. The effects of Taraxacum officinale extracts (TOE) supplementation on physical fatigue in mice. Afr. J. Tradit. Complement. Altern. Med. 8, 128-133.
26 Kang, M. J. and Kim, K. S. 2001. Current trends of research and biological activities of dandelion. Food Industry Nutr. 6, 60-67.
27 Katrin, S., Carle, R. and Schieber, A. 2006. Taraxacum - a review on its phytochemical and pharmacological profile. J. Ethnopharmacol. 107, 313-323.   DOI
28 Kovac, J. R., Pastuszak, A. W., Lamb, D. J. and Lipshultz L. I. 2014. Testosterone supplementation therapy in the treatment of patients with metabolic syndrome. Postgrad. Med. 126, 149-156.   DOI
29 Kim, K. M., Kim, Y. N., Choi, B. K. and Oh, D. H. 2012. Biological activity of Dandelion (Taraxacum officinale) extracts fermented with raw sugar. Kor. J. Food Sci. 44, 607-612.   DOI
30 Kim, T. W. and Kim, T. H. 2011. Pancreatic lipase inhibitors in the roots of Taraxacum ohwianum, a herb used in Korean traditional medicine. Kor. J. Food Preserv. 18, 53-58.   DOI
31 Koseoglu, R. D., Erdemir, F., Parlaktas, B. S., Filiz, N. O., Uluocak, N. and Etikan, I. 2007. Effect of chronic prostatitis on angiogenic activity and serum prostate specific antigen level in benign prostatic hyperplasia. Kaohsiung J. Med. Sci. 23, 387-394.   DOI
32 Lee, B. R., Lee, J. H. and An, H. J. 2012. Effects of Taraxacum officinale on fatigue and immunological parameters in mice. Molecules 17, 13253-13265.   DOI
33 Pöss, J., Custodis, F., Werner, C., Weingärtner, O., Böhm, M. and Laufs, U. 2011. Cardiovascular disease and dyslipidemia: beyond LDL. Curr. Pharm. Des. 17, 861-870.   DOI
34 Lee, H. H. and Lee, S. Y. 2008. Cytotoxic and antioxidant effects of Taraxacum coreanum Nakai. and T. officinale WEB. extracts. Kor. J. Med. Crop Sci. 16, 79-85.
35 Li, Y., Li, X., Fan, H., Li, X., Zhong, Y., Cao, J., Yu, D., Zhang, M., Wen, J. G., Geng, L. and Suo, Z. 2015. Age-dependent sex hormone-binding globulin expression in male rat. Ultrastruct. Pathol. 39, 121-130.   DOI
36 Liu, Y. J., Shieh, P. C., Lee, J. C., Chen, F. A., Lee, C. H., Kuo, S. C., Ho, C. T., Kuo, D. H., Huang, L. J. and Way, T. D. 2014. Hypolipidemic activity of Taraxacum mongolicum associated with the activation of AMP-activated protein kinase in human HepG2 cells. Food Funct. 5, 1755-1762.   DOI
37 Martinez, M., Poirrier, P., Chamy, R., Prufer, D., Schulze-Gronover, C., Jorquera, L. and Ruiz, G. 2015. Taraxacum officinale and related species - An ethnopharmacological review and its potential as a commercial medicinal plant. J. Ethnopharmacol. 169, 224-262.
38 Miner, M., Barkin, J. and Rosenberg, M. T. 2014. Testosterone deficiency: myth, facts, and controversy. Can. J. Urol. Suppl 2, 39-54.
39 Opuwari, C. S. and Monsees, T. K. 2015. Reduced testosterone production in TM3 Leydig cells treated with Aspalathus linearis (Rooibos) or Camellia sinensis (tea). Andrologia 47, 52-58.   DOI
40 Rato, L., Alves, M. G., Duarte, A. I., Santos, M. S., Moreira, P. I., Cavaco, J. E. and Oliveira, P. F. 2015. Testosterone deficiency induced by progressive stages of diabetes mellitus impairs glucose metabolism and favors glycogenesis in mature rat Sertoli cells. Int. J. Biochem. Cell Biol. 66, 1-10.   DOI
41 Singh, P. 2013. Andropause: Current concepts. Indian J. Endocrinol. Metab. 17, S621-629.   DOI
42 Raverot, V., Lopez, J., Grenot, C., Pugeat, M. and Déchaud, H. 2010. New approach for measurement of non-SHBG-bound testosterone in human plasma. Anal. Chim. Acta. 658, 87-90.   DOI
43 Regis, L., Planas, J., Celma, A., de Torres, I. M., Ferrer, R. and Morote, J. 2015. Behavior of total and free serum testosterone as a predictor for the risk of prostate cancer and its aggressiveness. Actas. Urol. Esp. 39, 573-581.
44 Rubinow, K. B., Vaisar, T., Tang, C., Matsumoto, A. M., Heinecke, J. W. and Page, S. T. 2012. Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity. J. Lipid Res. 53, 1376-1383.   DOI
45 Vinken, M. 2013. The adverse outcome pathway concept: a pragmatic tool in toxicology. Toxicology 4, 158-165.
46 Staerman, F. and Léon, P. 2012. Andropause (androgen deficiency of the aging male): diagnosis and management. Minerva Med. 103, 333-342.
47 Swerdloff, R. S. and Wang, C. 2004. Andorgen and ageing male. Best Pract. Res. Clin. Endocrinol. Metab. 18, 349-362.   DOI
48 Tsujimura, A. 2013. The Relationship between testosterone deficiency and men's health. World J. Mens Health 31, 126-135.   DOI
49 Walker, W. H. 2010. Non-classical actions of testosterone and spermatogenesis. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 365, 1557-1569.   DOI
50 Werner, R. and Holterhus, P. M. 2014. Androgen action. Endocr. Dev. 27, 28-40.